Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Franklin Genomic Advancements ETF (HELX)

Franklin Genomic Advancements ETF (HELX)
27.50 -0.91 (-3.20%) 09:30 ET [NYSE Arca]
28.79 x 600 28.90 x 600
Realtime by (Cboe BZX)
28.79 x 600 28.90 x 600
Realtime - - (-) -
Profile for Mon, Mar 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Overview

Name Franklin Genomic Advancements ETF
Fund Family Franklin Templeton
Underlying Index Solactive Genomics Index
Inception Date 02/25/20
First Trade Date 02/27/20
Leverage Long
Asset Class Equity

Sector:

N/A

Description:

The Franklin Genomic Advancements ETF seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life.

Investment Information

Alpha 0.00
60-Month Beta 1.02
Standard Deviation +0.56
Shares Outstanding, K 400.00
Managed Assets, $K 11,363.80 K
Net Asset Value 28.41
First Trade Price 24.00
P/E Ratio 18.88
Management Fee 0.50%
Options Yes
Latest Dividend 0.004
Last Dividend Date 12/30/21
Annual Dividend 0.00
Annual Dividend Yield 0.00%
1-Year Return -13.55%
3-Year Return -21.89%
5-Year Return 29.68%
Management Expense Ratio 0.50%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals